Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Brain Tumours and Microbiota: Gut, Oral and Intratumoural Signals

A Nature Reviews Neurology review examines how gut, oral and intratumoural microbes may shape brain tumour biology, treatment response and research methods.

By Dr. Revathy Mohan V.R., MBBS · Oct 19, 2026 · 5 min read

Oncology·Br J Cancer

G-CODE predicts mortality in older cancer patients across two French cohorts

The G-CODE score predicted 6-, 12- and 24-month mortality in older adults with cancer in French training and…

Oct 19, 2026

Oncology·Br J Cancer

DSRCT workshop prioritizes fusion targeting and new trial strategies

Experts on desmoplastic small round cell tumours prioritized fusion-driven targets, TCR therapy, ADCs, and global trial collaboration to…

Oct 19, 2026

Oncology·Br J Cancer

STING Agonist BI 1703880 Boosts Radiotherapy Anti-Tumour Response

Preclinical data show systemic BI 1703880 activates STING, is tolerated at low repeated doses, and strengthens radiotherapy-driven anti-tumour…

Oct 19, 2026

Oncology·Br J Cancer

Head and Neck Cancer Treatment Delays Worsen in England

Real-world English data show rising head and neck cancer waits, with referral route, hospital type and deprivation shaping…

Oct 19, 2026

Oncology·Br J Cancer

Antibody-Drug Conjugates Gain Ground in Gastrointestinal Cancers

A review of antibody-drug conjugates in gastrointestinal cancers describes emerging targets, payload shifts, and barriers to broader clinical…

Oct 19, 2026

Oncology·ACC-PRO

Nouscom raises 120M euros for Lynch syndrome cancer vaccine trial

Nouscom secured 120 million euros to advance NOUS-209 into a registration-enabling trial for Lynch syndrome cancer interception.

Oct 19, 2026

Oncology·Harvard Health

PSMA Scans Complicate Management of Recurring Prostate Cancer

PSMA imaging is exposing hidden prostate cancer recurrence and forcing a rethink of when men can safely delay…

Oct 19, 2026

Oncology·ScienceDaily

PPARD activation may turn immune cells into stronger cancer killers

Activating PPARD in immune cells boosted fat burning and tumor killing in lab models of colorectal, breast, ovarian…

Oct 19, 2026

Oncology·ScienceDaily

USC engineers renewable immune cells to fight cancer

USC researchers created expandable GMP immune cells that can be engineered to attack tumors and restore bacterial defense…

Oct 19, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.